摘要
目的:分析血必净注射液与利奈唑胺联合治疗重症肺炎患者的临床效果。方法:选择某院呼吸内科接收的重症肺炎患者84例作为研究对象,时间段为2016年5月~2018年11月,按照随机抽取方法分为对照组和研究组各42例,对照组单纯给予利奈唑胺注射液治疗,研究组则实施利奈唑胺、血必净注射液联合治疗方法,将两组的临床疗效、肺功能指标以及临床症状改善情况作比较。结果:较之对照组,研究组的治疗有效率更高,对比差异性明显,存在统计学意义(P<0.05);治疗前两组的肺功能比较无差异(P>0.05),治疗后研究组的MMF、FEV1/FVC水平更高,PEF更低(P<0.05);研究组的血常规恢复正常、痰液颜色改变、体温恢复正常时间均较对照组更短,比较差异性明显(P<0.05)。结论:临床上用利奈唑胺、血必净注射液联合法治疗重症肺炎的效果更好,可有效临床症状、肺功能指标改善,总体治疗效果显著,值得推广应用。
Objective:To analyze the clinical effect of Xuebijing injection combined with linezolid in patients with severe pneumonia.Methods:84 patients with severe pneumonia received by respiratory department of a hospital from may 2016 to november 2018 were selected as the research subjects and divided into two groups according to the random sampling method.The control group was treated with linezolid injection alone,and the study group was treated with linezolid combined with Xuebijing injection,then the clinical efficacy,pulmonary function index and clinical symptom improvement of the two groups were compared.Results:Compared with the control group,the effective rate of treatment in the study group was higher.There was statistical significance(P<0.05).There was no difference in pulmonary function between the two groups before treatment(P>0.05),while the MMF and FEV1/FVC level were higher and the PEF was lower in the study group after treatment(P<0.05).The times of routine blood returned to normal,sputum color changes,and body temperature returned to normal in the study group were shorter than those in the control group,and the difference was obvious(P<0.05).Conclusion:The clinical effect of combination of linezolid and Xuebijing injection in the treatmeht of severe pneumonia is better,which can improve the clinical symptoms and pulmonary function index,with significant overall treatment effect,and is worthy of promotion and application.
作者
候玉伟
Hou Yuwei(ICU,Anyang District Hospital,Anyang City,Henan Province,Anyang 455000)
出处
《数理医药学杂志》
CAS
2021年第11期1662-1664,共3页
Journal of Mathematical Medicine
关键词
重症肺炎
利奈唑胺
血必净
临床疗效
severe pneumonia
linezolid
Xuebijing
clinical effect
